A DOSE-ESCALATION STUDY OF HIGH-DOSE INTERFERON-ALPHA 2A (HDIFN) UP TO 18 MILLION UNITS DAILY IN PATIENTS WITH POOR-PROGNOSIS CHRONIC MYELOID-LEUKEMIA (CML) OR GOOD PROGNOSIS PATIENTS WHO HAVE FAILED TREATMENTWITH IFN PLUS CYTOSINE-ARABINOSIDE (ARA-C)
Ck. Arthur et al., A DOSE-ESCALATION STUDY OF HIGH-DOSE INTERFERON-ALPHA 2A (HDIFN) UP TO 18 MILLION UNITS DAILY IN PATIENTS WITH POOR-PROGNOSIS CHRONIC MYELOID-LEUKEMIA (CML) OR GOOD PROGNOSIS PATIENTS WHO HAVE FAILED TREATMENTWITH IFN PLUS CYTOSINE-ARABINOSIDE (ARA-C), Blood, 88(10), 1996, pp. 2291-2291